bimagrumab and semaglutide Eli Lilly's Next-Gen Obesity Therapies: A New Era of Clinical Dominance? Antibody blockade of activin type

Before, I'd constantly think about snacks, but now I feel more in control

Several GLP-1 receptor agonists have demonstrated cardiovascular benefits in specific populations, with varying magnitudes of risk reduction for major adverse cardiovascular events in landmark trials

Its biology, not weakness

We want to help plan sponsors understand that cohort and build benefits around it, not just to reduce the likelihood of a stroke or heart attack, but to advance benefits equity within their plans

This combination of increased fat storage around the abdomen and a reduced metabolic rate makes weight gain more likely during menopause, even if a woman maintains the same diet and exercise routine as before